Novo Seeds Founded 2007
Founders
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 102
Average round size
info
The average size of a deal this fund participated in
$33M
Portfolio companies 102
Rounds per year 7.29
Lead investments 42
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Exits -
Key employees -
Stages of investment
Early Stage Venture
Late Stage Venture
Post-Ipo
Private Equity
Seed
Areas of investment
Biotechnology
Health Care
Medical
Pharmaceutical
Therapeutics
Summary

Novo Seeds is the famous VC, which was founded in 2007. The leading representative office of defined VC is situated in the Hellerup. The fund was located in Europe if to be more exact in Denmark.

Among the most popular portfolio startups of the fund, we may highlight Galecto Biotech. Among the most successful fund investment fields, there are Biopharma, Chemical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Denmark. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Novo Seeds, startups are often financed by M Ventures, SEED Capital, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are M Ventures, Sofinnova Investments, Lundbeckfonden Emerge. In the next rounds fund is usually obtained by M Ventures, Sunstone Life Science Ventures, Lundbeckfonden Emerge.

Besides them, we counted 5 critical employees of this fund in our database.

The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies. The higher amount of exits for fund were in 2014. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2018. Despite it in 2019 the fund had an activity. Comparing to the other companies, this Novo Seeds performs on 22 percentage points less the average number of lead investments.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
NMD Pharma
Biotechnology
Medical
Pharmaceutical
Series A
38M23 Mar 2018 Denmark, Aarhus
Affimed
Biotechnology
Health Care
Therapeutics
Series D
15M08 Oct 2012 Germany, Heidelberg
Orphazyme
Biotechnology
Genetics
Health Diagnostics
Therapeutics
Post-IPO Equity
80M24 Nov 2017 Denmark, Copenhagen
Biosyntia
Biopharma
Biotechnology
Clinical Trials
Manufacturing
Medical Device
Seed
1M21 May 2015 Denmark, Hørsholm
Glycomine
Biotechnology
Pharmaceutical
Therapeutics
Series B
33M07 Aug 2019 Panama, San Francisco
Entasis Therapeutics
Biotechnology
Health Care
Medical
Pharmaceutical
Series B
50M04 Apr 2016 United States, Waltham
SI-BONE
Health Care
Health Diagnostics
Hospital
Venture - Series Unknown
33M28 Apr 2014 United States, San Jose
Salmedix Inc
Biotechnology
Health Care
Medical
Series C
45M19 Oct 2005 United States, San Diego
VectivBio
Biotechnology
Health Care
Medical
Series A
35M08 Jan 2020 Switzerland, Basel
Orphazyme
Biotechnology
Genetics
Health Diagnostics
Therapeutics
Seed
14 Feb 2011 Denmark, Copenhagen
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Novo Seeds?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: